Structure and properties of pharmacologically active polymers
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Although the concept of using pharmacologically active macromolecular compounds as drugs is still regarded with much skepticism for both theoretical and practical reasons, interest in this field has grown in recent years because of the opportunity to take advantage of the specific properties of polymeric materials. For low molecular weight drugs, changes in structure often lead to a loss of specific activity. On the other hand, the properties of macromolecular drugs depend on the structure of the polymer used and this can be varied over a wide range by the incorporation of comonomer units, by the application of polymer‐analogous reactions, or by related structural changes. A new model is presented for pharmacologically active polymers which incorporates the possibility for continuous variation in (a) solubility and toxicity, (b) fixation and removal of active material, and (c) body distribution. Using the new model as a guide, examples of the synthesis and study of the biological activity of various macromolecular drugs are presented in order to emphasize the importance of this cooperative effort between polymer research and therapeutic problems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The drug-polymer conjugates were introduced in the early work by Helmut Ringsdorf in 1970s to improve drug solubility, toxicity, and body biodistribution, which was followed by extensive studies on the development of drug-polymer conjugates [143, 144].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [144]
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Chang, T. M. S. (1964) · Science · doi:10.1126/science.146.3643.524 · Cited by 1,011
Lysosomes in Biology and Pathology
Lagunoff, D. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230160059035 · Cited by 887
AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGES
Allison, A. C., Harington, J. S., & Birbeck, M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.2.141 · Cited by 871
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
Boneu, B., Abbal, M., Plante, J., & Bierme, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92650-1 · Cited by 716
de Duve, C. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470715314.ch1 · Cited by 473
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Ryser, H. J.-P. (1968) · Science · doi:10.1126/science.159.3813.390 · Cited by 288
Research works printed but not linked: 20
- Lee H., 1971, Handbook for Surgery and Artificial Organs
- Kabaiwanow W., 1972, Plaste Kaut., 19, 886
- Wessel W., 1971, Arzeim. Forsch., 21, 1468
- Ryser H. J. P., 1970, Proc. Fourth Int. Cong. Pharm., 3, 96
- 1965, Silikose Forsch., 6, 213
- Ferruti P., 1966, Med. Lav., 57, 481
- V.Hofmann dissertation University of Mainz 1975.
- Burger A., 1970, Medicinal Chemistry, 1185
- Donaruma L. G., 1974, Prog. Polym. Sci., 4, 18
- G.Franzmann dissertation University of Mainz 1975.
- H.Morawetzet al. in press.
- Ringsdorf H., 1967, Strahlentherapie, 132, 627
- Busch H., 1961, Cancer Res., 21, 271
- H.Ritter dissertation University of Mainz 1975.
- M.Przybylski dissertation University of Mainz 1975.
- Jacob S. W., 1971, Dimethylsulfoxide
- V.Hofmann H.Ringsdorf andG.Muacevic Makromol. Chem. in press.
- Jacques P. J., 1966, Rev. Quest. Sci., 27, 99
- Jacques P. J., 1969, Lysosomes in Biology and Pathology, 395
- Szekerke M., 1972, Neoplasma, 19, 211
Cited by
Items 901–1,000 of 1,000
Some Perspectives on Targeted Delivery with Prodrugs
Sinkula, A. A. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb45808.x · Cited by 3
Conjugates, Polymer–Drug: Targeted Cancer Treatment
Singh, A. V., Raichur, A. M., & Dyawanapelly, S. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050560 · Cited by 3
Parodi, A., Khaled, S. M., Yazdi, I. K., Evangelopoulos, M., Furman, N. E. T., Wang, X., Urzi, F., Hmaidan, S., Hartman, K. A., & Tasciotti, E. (2016) · Springer eBooks · doi:10.1007/978-94-017-9780-1_104 · Cited by 3
Han, J.-C., Yang, F., Wang, M., Wang, M., & Xing, N. (2022) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2022.110060 · Cited by 3
RetractedApplication of Ionic Polymers in Medicine
Hutchinson, F. (1986) · Springer eBooks · doi:10.1007/978-94-009-4187-8_7 · Cited by 3
Important Classes of Compounds
Troev, K. D. (2006) · Elsevier eBooks · doi:10.1016/b978-044452737-0/50005-3 · Cited by 2
Torchilin, V. P. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-1976-7_13 · Cited by 2
Recent Progress in Polymer Therapeutics as Nanomedicines
Dangoor, S. I., Michael, S. K., Baabur‐Cohen, H., Omer, L., & Satchi‐Fainaro, R. (2020) · doi:10.1201/9781003125259-5 · Cited by 2
Review on History and Evolution of Nanoparticles and Applications in Various Fields
Guttula, R. S. (2020) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2020.32497 · Cited by 2
Choudhary, S., Sethi, S., Dudhe, R., Dudhe, A. R., Sharma, R., Bajwa, N., Singh, P. A., Baldi, A., Madan, J., & Singh, K. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91663-9.00003-5 · Cited by 2
Magic shotgun over magic bullet for treatment of ovarian cancer via polymeric nanoparticles
Ahmed, B., Sharma, A., Usmani, Z., Sharma, G., Singh, J., Yadav, R., Sharma, I., & Kaur, I. P. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104945 · Cited by 3
Joseph, P. B., Babu, S. K. S., Selvin, J., & Sree, H., V (2024) · Indian Journal of Physics · doi:10.1007/s12648-024-03437-4 · Cited by 2
Specialized Drug Delivery Systems: An Overview
Garg, S., Kumar, M., Maurya, R. K., Alam, M. I., Karwal, A., Yadav, A. K., Yadav, V. K., & Shukla, A. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4970-6_16 · Cited by 3
Release of 2-aminothiazole from polymer carriers
Chafi, N., Monthéard, J. P., & Vergnaud, J. M. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90209-7 · Cited by 2
Cardiovascular Nanomedicine: Materials and Technologies
Gupta, A. S. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_13 · Cited by 3
Fante, C., & Greco, F. (2013) · Wiley eBooks · doi:10.1002/9781118747896.ch3 · Cited by 2
Buccal and Sublingual Drug Delivery
Hillery, A., & Park, K. (2016) · CRC Press eBooks · doi:10.1201/9781315382579-9 · Cited by 2
Biodegradable Multitargeting Nanoconjugates for Drug Delivery
Ljubimova, J. Y., Black, K. L., Ljubimov, A. V., & Holler, E. (2008) · Fundamental biomedical technologies · doi:10.1007/978-0-387-76554-9_8 · Cited by 2
Synthesis and hydrolysis of esters from amylose and nicotinoyl chloride
Sánchez‐Chaves, M., & Arranz, F. (1988) · Die Makromolekulare Chemie · doi:10.1002/macp.1988.021891006 · Cited by 2
Poly (L-glutamic acid)-Paclitaxel Conjugates for Cancer Treatment
Zhang, S. (2012) · InTech eBooks · doi:10.5772/21474 · Cited by 2
“In 1975, the concept of a polymer-drug conjugate was first proposed by Ringsdorf (Ringsdorf, 1975).”
Core/Shell Nanoparticles for Drug Delivery and Diagnosis
Lee, H., Kim, J. Y., Lee, E. H., Park, Y. I., Oh, K. S., Kim, K., Kwon, I. C., & Yuk, S. H. (2013) · Wiley eBooks · doi:10.1002/9781118644591.ch9 · Cited by 3
Lin, Z., Shi, L., & Huang, J. (2000) · Journal of Macromolecular Science Part A · doi:10.1081/ma-100101090 · Cited by 2
Synthesis of a Polymeric Doxorubicin Derivative and its Evaluation Using IR and UV Spectroscopy
Жукова, О. В., & Булгакова, С. А. (2015) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-015-1204-1 · Cited by 2
Synthesis and Characterization of 5-Fluorouracil and Polyethylene Glycol Esters as Prodrugs
Li, C. W., Li, G., & Zuo, J. C. (2011) · Advanced materials research · doi:10.4028/www.scientific.net/amr.287-290.1509 · Cited by 2
“[1][2] We chose polyethylene glycol(PEG) as polymer carrier because it is known to be non-toxic, no-antigenic and biocompatible, to be soluble in water and organic solvent and by itself to have solubilizing properties.”
MethodMacromolecular Design of Platinum Drug Conjugates
Koseva, N. S. (2014) · Clinical Pharmacology & Biopharmaceutics · doi:10.4172/2167-065x.s2-006 · Cited by 2
Preparation of Nanocapsules Formed from Temperature-Responsive Block Polymers Containing PEG
Iijima, M., & NAKAJIMA, S. (2012) · KOBUNSHI RONBUNSHU · doi:10.1295/koron.69.102 · Cited by 2
Posavec, D., Müller, R., Bogner, U., Bernhardt, G., & Knör, G. (2014) · Biomaterials & biomedical engineering · doi:10.12989/bme.2014.1.2.073 · Cited by 2
“Since the pioneering studies on pharmacologically active polymers (Ringsdorf 1975), there has been a continuous improvement of covalently and non-covalently bound carrier-drug conjugates (Khandare and Minko 2006, Larson and Ghandehari 2012).”
BackgroundPolymer–Drug Conjugates for Treating Local and Systemic Fungal Infections
Francis, A. P., & Jayakrishnan, A. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012638-00303 · Cited by 2
Ebara, M., Kotsuchibashi, Y., Uto, K., Aoyagi, T., Kim, Y., Narain, R., Idota, N., & Hoffman, J. M. (2014) · NIMS monographs · doi:10.1007/978-4-431-54400-5_6 · Cited by 2
Emerging applications of bionanomaterials in medicine and drug delivery
Gugulothu, D. B., & Khatri, D. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823915-5.00012-5 · Cited by 2
Biological Activity of Oxidized Polysaccharides
Negulescu, I. I., & Uglea, C. V. (2006) · Springer eBooks · doi:10.1007/1-4020-3794-5_8 · Cited by 2
“As early as the 1980s it was reported that the normal mechanism whereby such a polymer passes the cell membrane is by endocytosis [ 60 ].”
BackgroundCaracterísticas hidrodinámicas de carboximetilquitina y carboximetilquitosana
Monagas, F., & Amalia, S. (2000) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Kühn, M., Pommerening, K., Mohr, P., Benes, M., & Štamberg, J. (1981) · Die Angewandte Makromolekulare Chemie · doi:10.1002/apmc.1981.050970115 · Cited by 2
Hydrolyses of polymeric Schiff bases in acidic medium
Month�ard, J.-P., Vergnaud, J. M., & Kolli, M. (1990) · Polymer Bulletin · doi:10.1007/bf01032449 · Cited by 2
Polymer‐drug conjugates: Manipulation of drug delivery kinetics
Pitt, C. G., Wertheim, J. A., Wang, C. T., & Shah, S. S. (1997) · Macromolecular Symposia · doi:10.1002/masy.19971230122 · Cited by 2
Zhang, Y., Won, C.-Y., & Chu, C. (1999) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/(sici)1099-0518(19991215)37:24<4554::aid-pola13>3.0.co;2-t · Cited by 74
The persistent radical effect in controlled radical polymerizations
Fischer, H. (1999) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/(sici)1099-0518(19990701)37:13<1885::aid-pola1>3.0.co;2-1 · Cited by 352
Tong, R., Tang, L., Gabrielson, N. P., Yin, Q., & Cheng, J. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse494 · Cited by 2
Bioinspired Engineering of Intelligent Drug Delivery Systems and Protein-Polymer Conjugates
Stayton, P. S., Hoffman, A. S., Press, O. W., Murthy, N., Lackey, C. A., Cheung, C., Shimoboji, T., Ding, Z., Black, F. E., Campbell, J. S., et al. (2002) · CRC Press eBooks · doi:10.1201/9780203908976-21 · Cited by 2
Systemic Cancer Therapy Using Polymer-Based Prodrugs and Progenes
Seymour, L. W. (2001) · CRC Press eBooks · doi:10.1201/9780203904671-33 · Cited by 2
Peptidomimetic Polymers: Advances in Monomer Design and Polymerization Methods
Chan, B. A. (2016) · Louisiana State University · doi:10.31390/gradschool_dissertations.3676 · Cited by 2
Chemical Aspects of Enzyme Stabilization and Modification for Use in Therapy
Torchilin, V. P., Mazaev, A. V., Ильина, Е. В., Goldmacher, V. S., Smirnov, V. N., & Chazov, E. I. (1980) · Springer eBooks · doi:10.1007/978-1-4684-3719-5_6 · Cited by 2
Elias, H. (1984) · Springer eBooks · doi:10.1007/978-1-4899-2809-2_9 · Cited by 2
Pharmacokinetic Strategies in the Development of Prodrugs
Balant, L. P., Doelker, É., & Buri, P. A. (1991) · Springer eBooks · doi:10.1007/978-1-4684-8053-5_16 · Cited by 2
A Review on the Role of Polymers in Pharmaceutical Applications
Alkadi, H. (2020) · Venoms and Toxins · doi:10.2174/2666121701999201116154850 · Cited by 1
“The proposed model of Helmut Ringsdorf consists fundamentally of the following ingredients: (i) macromolecular polymeric backbone, (ii) drug, (iii) spacer, (iv) targeting moiety and (v) solubilizing agent [10-12].”
MethodChaudhary, S., Khodakiya, A., Ankit, C., & Patel, J. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-15848-3_7 · Cited by 1
Silver Nanoparticles Capped with Poly[(maleic anhydride)-co-(vinyl acetate)]
Ayas, G., & Karakuş, G. (2023) · Cumhuriyet Science Journal · doi:10.17776/csj.1192585 · Cited by 1
“The model basically is based on synthetic covalent bond interaction between the pharmaceutically active substances and a polymer backbone [4].”
A Comprehensive Review on Advancement in Nano Polymer System for Drug Targeting
Paramanick, D., Modi, D., Farheen, & Nagarani, K. (2025) · Wiley eBooks · doi:10.1002/9781394234134.ch10 · Cited by 2
Shanmugesh, A. M., Venkatapathy, M., Sekar, K. G., & Anbarasu, K. (2025) · RASAYAN Journal of Chemistry · doi:10.31788/rjc.2025.1829281 · Cited by 1
Polymeric Drugs via Multicomponent Reactions
Ma, Z., Zhu, C., & Tao, L. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202500731 · Cited by 1
Govender, T. R., Matshe, W. M. R., Dube, N., Cele, Z. E. D., Williams, A. A., Pilcher, L. A., & Balogun, M. O. (2026) · Advanced Therapeutics · doi:10.1002/adtp.202500418 · Cited by 2
Fuchs, A., & Nuhn, L. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114952 · Cited by 2
Backbone Degradable and Coiled‐Coil Based Macromolecular Therapeutics
Yang, J., & Kopec̆ek, J. (2014) · Wiley eBooks · doi:10.1002/9783527672752.ch1 · Cited by 2
Complex impedance spectroscopy to investigate degradable chondroitin–poly(amino-serinate) complexes
Balme, S., Rixte, J., Boustta, M., Vert, M., & Henn, F. (2013) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2013.08.028 · Cited by 1
Bridging Polymer Science and Medicine Through Supramolecular Nanoassemblies
Cabral, H., & Kataoka, K. (2013) · Advances in polymer science · doi:10.1007/12_2013_271 · Cited by 1
Multifunctional Polymer Architectures
(2016) · Wiley eBooks · doi:10.1002/9781119188896.ch5 · Cited by 1
MECHANISTIC APPROACHES TO PHASE I CLINICAL TRIALS
Ferry, D. R., & Kerr, R. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50021-8 · Cited by 1
Enzymatically Synthesized Polyesters for Drug Delivery
Lu, S., Ding, J., Chen, J., Wang, W., Zhuang, X., & Chen, X. (2016) · Pan Stanford eBooks · doi:10.1201/b20045-4 · Cited by 1
Polymer Conjugates of Proteins and Drugs to Improve Therapeutics
Kanaujia, P., & Ajazuddin, M. (2014) · Wiley eBooks · doi:10.1002/9781118860168.ch12 · Cited by 1
research on the tpe biodegradable biomedical polymer materials
Jin, J. (2015) · Advances in computer science research · doi:10.2991/iccset-14.2015.112 · Cited by 1
Chemical and Biological Aspects of Peptide Catecholamine Conjugates
Goodman, M., Verlander, M. S., & Kaplan, N. O. (1979) · Journal of Macromolecular Science Part A - Chemistry · doi:10.1080/00222337908066611 · Cited by 1
Chemical Reaction Controlled Release
Fan, L., & Singh, S. K. (1989) · Springer eBooks · doi:10.1007/978-3-642-74507-2_3 · Cited by 1
Targeted Drug Delivery in Oncology: Current Paradigm and Challenges
Stirland, D. L., & Bae, Y. H. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737388-00001 · Cited by 1
A redox-sensitive polymer-drug conjugate for tumor therapy: synthesis, properties and performance
Song, K., Wang, X., Liang, X. H., Liu, M., Zhou, Y., Zhang, G., & Chen, L. (2019) · Materials Research Express · doi:10.1088/2053-1591/ab3b37 · Cited by 1
4.27 Polymeric Drug Conjugates by Controlled Radical Polymerization
Kim, S.-H., Nguyen, T. H. T., & Maynard, H. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100691-7.00020-3 · Cited by 2
Targeted Nanomedicine in Chemoprevention
Paliwal, R., & Paliwal, S. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-9692-6_5 · Cited by 1
Nanoformulations of old and new antimalarial drugs
Alven, S., & Aderibigbe, B. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821100-7.00010-8 · Cited by 2
PEGYLATION: CONCEPT AND APPLICATIONS IN CANCER THERAPEUTICS
Khan, T. A., & Gohel, A. K. (2014) · INDIAN DRUGS · doi:10.53879/id.51.04.p0005 · Cited by 1
Evaluation of Nanoparticle Stability under Blood Flow Shear
Guo, W. X., Hu, L. F., Feng, Y. H., Liu, Y., Jing, L. Y., Chen, B. Z., & Guo, X. D. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c02367 · Cited by 1
Zentel, R. (2023) · Liquid Crystals · doi:10.1080/02678292.2023.2213058 · Cited by 1
“As a result, the research of the Ringsdorf lab in the late 70s and throughout the 80s explored various aspects of ‘Self-Organized Systems’ [8,10] (see Figure 2, LC-phases, lipid layers and liposomes) as well as on ‘Polymers for Antitumoral Applications’ [5,6], whereby the aspect of antitumor polymers and liposomes (an…”
BackgroundClick Chemistry in Polymer Science
Gür, I. Y., Abdelmohsen, L. K. E. A., & van Hest, J. C. M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781839169885-00001 · Cited by 5
Sundararajan, R., & Dhamodharan, R. (2004) · Journal of Macromolecular Science Part A · doi:10.1081/ma-120037347 · Cited by 1
Synthèse de copolymères supports de sulfanilamide. Hydrolyses dans un milieu gastrique de pH=1.2
Chafi, N., Benghalem, A., & Mesli, A. (2003) · European Polymer Journal · doi:10.1016/s0014-3057(02)00345-2 · Cited by 1
Review : Oligomeric Drug Carriers
Ferruti, P., & Pozzo, A. D. (1987) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391158700200205 · Cited by 1
Bauduin, G., Bessière, J., Martel, J., & Pietrasanta, Y. (1984) · Die Makromolekulare Chemie · doi:10.1002/macp.1984.021851113 · Cited by 1
Lin, Z., Huang, Z. R., Shi, L., & Huang, J. (2000) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/1099-0518(20000715)38:14<2548::aid-pola50>3.0.co;2-s · Cited by 1
Synthese polymergebundener Antiphlogistika
Roth, H. J., & Kallmeyer, G. (1988) · Archiv der Pharmazie · doi:10.1002/ardp.19883210507 · Cited by 1
Tradition and innovation in science
Mertesdorf, C., Ringsdorf, H., Mertesdorf, C., & Ringsdorf, H. (2006) · Liquid Crystals · doi:10.1080/02678290601119864 · Cited by 1
Self-citationSynthesis of Phosphorus-Containing Polymers with Aziridine Ring
Trendafilova‐Gercheva, D., Troev, K., & Georgieva, M. (1991) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.64.2035 · Cited by 1
The place of polymer prodrugs in cancer therapy
Coxon, F. Y., & Cassidy, J. (2000) · Emerging Drugs · doi:10.1517/14728214.5.4.457 · Cited by 1
NanoDDS 2013: The 11th International Nano Drug Delivery Symposium
MacKay, J. A., Almutairi, A., Hennink, W. E., & Hoffman, A. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.052 · Cited by 1
“published a prescient article on polymer–drug conjugates [5].”
BackgroundElias, H. (1977) · Springer eBooks · doi:10.1007/978-1-4615-7364-7_23 · Cited by 1
Kim, G. J. (2007) · SMARTech Repository (Georgia Institute of Technology) · Cited by 2
A Hydrodynamic Approach To CancerPreprint
Pinkowski, A., & Lilienblum, W. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/014696 · Cited by 1
“Modeling of pharmacologically active polymers is still based on Ringsdorf's propositions (Ringsdorf, 1975).”
BackgroundPatil, V. (2011) · Digital Repository Service (Northeastern University) · doi:10.17760/d20002441 · Cited by 1
Larionova, N. I., & Torchilin, V. P. (1980) · Pharmaceutical Chemistry Journal · doi:10.1007/bf00777452 · Cited by 1
Arginine-Rich Ionic Complementary Peptides and Their Drug Delivery Potential
Wan, Z. (2013) · UWSpace (University of Waterloo) · Cited by 1
Medical Devices and Preparative Medicine: Polymer Drug Application
Aguilar, M. R., García‐Fernández, L., López-Donaire, M. L., Parra, F., Rojo, L., Rodríguez, G., Fernández‐Gutiérrez, M., & Román, J. S. (2017) · CRC Press eBooks · doi:10.1081/e-ebppc-120052267 · Cited by 2
Treetharnmathurot, B. (2009) · PSU Knowledge Bank (Prince of Songkla University) · Cited by 1
Nanoparticles: Biomaterials for Drug Delivery
Gokhale, A., Williams, T., & Vaughn, J. M. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050070 · Cited by 1
Drug Targeting with Polymeric Micelle Drug Carriers
Yokoyama, M. (2002) · CRC Press eBooks · doi:10.1201/9781420041187.ch11 · Cited by 2
Kontrollierte therapeutische Systeme (Controlled drug delivery systems)
Ha, S., & Wintermantel, E. (2008) · Springer eBooks · doi:10.1007/978-3-540-74925-7_73 · Cited by 1
Shtilman, M. I. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050545 · Cited by 1
Dudek, A. Z., & Powell, S. F. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse459 · Cited by 1
Miller, K., & Satchi‐Fainaro, R. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb462 · Cited by 1
Boztepe, T. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/155261 · Cited by 1
Development of Drug Customized Polymeric Carriers for Improved Therapeutic Efficiency
Abdelghafour, M. M. (2023) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11737 · Cited by 3
Développement de vecteurs pharmaceutiques pour le relargage contrôlé de principes actifs
Meur, A.-C. L. (2009) · theses.fr (ABES) · doi:10.70675/ae45f18dz0d29z49c4z9ed1z0f15eb943484 · Cited by 3
Synthesis and self-assembly of polysaccharide-b-elastin-like polypeptide bioconjugates
Xiao, Y. (2019) · theses.fr (ABES) · doi:10.70675/6ef63cffzc57fz4b2azaedcz5d50202fdccb · Cited by 2
(2000) · doi:10.1002/(sici)1099-0518(20000415)38:8
Metadata
- Authors
- Ringsdorf, H.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Ringsdorf, Helmut
- Venue
- Journal of Polymer Science: Polymer Symposia
- Publisher
- Wiley
- Published
- 1975-01
- Volume
- 51
- Issue
- 1
- Pages
- 135-153
- ISSN
- 0360-8905 (ISSN-L)
- 1936-0959
- OpenAlex
- W2098279377
- Cited by
- 1,094
- References
- 63
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 34 · 2023: 35 · 2022: 30 · 2021: 35 · 2020: 50 · 2019: 36 · 2018: 29 · 2017: 46 · 2016: 45 · 2015: 47 · 2014: 55 · 2013: 43 · 2012: 48
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Polymer Science Polymer Symposia (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- macromolecular drugs, comonomer incorporation, polymer-analogous reactions, solubility, toxicity, body distribution, polymer synthesis, biological activity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.